|
Market Closed -
Euronext Paris
01:55:00 25/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 36.80 EUR | -3.54% |
|
-3.16% | -14.52% |
| 06/08 | Neurones posts strong growth |  |
| 06/08 | NEURONES Raises Earnings Guidance for the Full Year 2026 | CI |
Company Valuation: NEURONES
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 920.3 | 950.8 | 1,062 | 1,067 | 1,047 | 910.5 | - | - |
| Change | - | 3.32% | 11.69% | 0.47% | -1.89% | -13.01% | - | - |
| Enterprise Value (EV) 1 | 655.7 | 679 | 771.5 | 747.4 | 710.1 | 579.1 | 546.8 | 509.5 |
| Change | - | 3.56% | 13.62% | -3.13% | -4.99% | -18.45% | -5.58% | -6.81% |
| P/E | 24.5x | 21.6x | 21.6x | 20.3x | 20.1x | 16.4x | 14.8x | 13.5x |
| PBR | 2.95x | 2.87x | 3x | 2.82x | 2.62x | 2.2x | 2.07x | 1.94x |
| PEG | - | 1.2x | 1.9x | 3.17x | -21.71x | 1.86x | 1.4x | 1.35x |
| Capitalization / Revenue | 1.59x | 1.43x | 1.43x | 1.32x | 1.22x | 1.01x | 0.96x | 0.92x |
| EV / Revenue | 1.13x | 1.02x | 1.04x | 0.92x | 0.83x | 0.64x | 0.58x | 0.51x |
| EV / EBITDA | 8.6x | 7.59x | 8.33x | 7.82x | 7.46x | 5.7x | 4.92x | 4.22x |
| EV / EBIT | 10.6x | 9.31x | 10.2x | 9.59x | 9.39x | 7.11x | 6.06x | 5.14x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1 | 1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Rate of return | 2.63% | 2.55% | 2.74% | 2.96% | 3.25% | 3.93% | 4.19% | 4.46% |
| EPS 2 | 1.55 | 1.82 | 2.03 | 2.16 | 2.14 | 2.328 | 2.576 | 2.833 |
| Distribution rate | 64.5% | 54.9% | 59.1% | 60.2% | 65.4% | 64.4% | 62.1% | 60% |
| Net sales 1 | 579.9 | 665.4 | 741.2 | 810.4 | 857.2 | 904.3 | 949.6 | 992.3 |
| EBITDA 1 | 76.28 | 89.44 | 92.61 | 95.58 | 95.14 | 101.6 | 111.1 | 120.7 |
| EBIT 1 | 61.6 | 72.9 | 75.9 | 77.9 | 75.6 | 81.39 | 90.21 | 99.23 |
| Net income 1 | 37.7 | 44.3 | 49.4 | 52.5 | 52.1 | 56.76 | 62.8 | 69.06 |
| Net Debt 1 | -264.6 | -271.8 | -290.4 | -319.5 | -336.6 | -331.5 | -363.8 | -401 |
| Reference price 2 | 38.00 | 39.25 | 43.75 | 43.95 | 43.05 | 38.15 | 38.15 | 38.15 |
| Nbr of stocks (in thousands) | 24,218 | 24,224 | 24,272 | 24,274 | 24,313 | 23,867 | - | - |
| Announcement Date | 9/2/22 | 8/2/23 | 6/3/24 | 5/3/25 | 11/3/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.39x | 0.64x | 5.7x | 3.93% | 1.06B | |
| 23.14x | 3.77x | 13.17x | 2.87% | 222B | |
| -116.79x | 18.57x | 106.98x | -.--% | 115B | |
| 13.73x | 1.52x | 7.97x | 3.49% | 113B | |
| 14.91x | 2.72x | 10.28x | 5.51% | 87.05B | |
| 20.45x | 5.36x | 13.17x | 2.79% | 62.19B | |
| 14.69x | 2.13x | 9.06x | 5.31% | 47.45B | |
| 20.59x | 1.68x | 10.33x | 1.42% | 39.79B | |
| 20.4x | 1.55x | 9.86x | 0.92% | 38.85B | |
| 17.74x | 2.3x | 10.68x | 4.87% | 36.84B | |
| Average | 4.52x | 4.02x | 19.72x | 3.11% | 76.4B | |
| Weighted average by Cap. | -1.61x | 5.28x | 25.53x | 2.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- NRO Stock
- Valuation NEURONES
Select your edition
All financial news and data tailored to specific country editions
